Pharmaceuticals US Pharma and Biotech Summit 2024: When FDA needs to regulate AI Last updated: May 17, 2024 7:07 pm By bexib 0 Min Read Share SHARE Tara Fakhoury spoke at the conference about the FDA’s approach to determining when the use of AI in the pharmaceutical industry needs to be regulated. You Might Also Like APL and CurifyLabs Partner to Support Patients with 3D Printed Medical Technology Phase 2 PREDICT-ILD Imaging Study in Interstitial Lung Disease Begins New ways to determine drug value with health equity in mind Melissa Krebs Shares Gersana’s Vision for Innovative Wound Care Solutions Zongertinib demonstrates high objective response rates in previously treated advanced non-small cell lung cancer Share This Article Facebook Twitter Email Print Previous Article How To Start a Skin Care Line in 11 Steps (2024) Next Article Infrastructure Week is no longer a punchline, but it hasn’t reached the stage either. Leave a comment Leave a Reply Cancel replyYour email address will not be published. Required fields are marked *Comment * Name * Email * Website Save my name, email, and website in this browser for the next time I comment. Stay ConnectedFacebookLikeTwitterFollowYoutubeSubscribeTelegramFollowLatest News Brintons launches first commercial carpet collection with V&A Hospitality & Tourism Editor’s Pick: Top 3 Features of 2024 Banking New e-commerce tools: December 26, 2024 Retail & E-commerce Is it a wise choice to join? Insurance